Legend Biotech (LEGN) Equity Average (2021 - 2025)
Historic Equity Average for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to $1.0 billion.
- Legend Biotech's Equity Average fell 1003.51% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 1003.51%. This contributed to the annual value of $1.1 billion for FY2024, which is 1484.37% up from last year.
- Per Legend Biotech's latest filing, its Equity Average stood at $1.0 billion for Q3 2025, which was down 1003.51% from $1.0 billion recorded in Q2 2025.
- Over the past 5 years, Legend Biotech's Equity Average peaked at $1.4 billion during Q3 2023, and registered a low of $273185.0 during Q2 2021.
- Over the past 5 years, Legend Biotech's median Equity Average value was $1.0 billion (recorded in 2025), while the average stood at $857.7 million.
- As far as peak fluctuations go, Legend Biotech's Equity Average surged by 3063863.45% in 2021, and later plummeted by 1716.84% in 2024.
- Legend Biotech's Equity Average (Quarter) stood at $495.9 million in 2021, then soared by 51.95% to $753.6 million in 2022, then soared by 71.92% to $1.3 billion in 2023, then decreased by 16.76% to $1.1 billion in 2024, then decreased by 5.09% to $1.0 billion in 2025.
- Its Equity Average was $1.0 billion in Q3 2025, compared to $1.0 billion in Q2 2025 and $1.0 billion in Q1 2025.